Study links migraine drug to higher kidney stone risk

04/9/2013 | MedPage Today (free registration)

Taking the migraine drug topiramate was associated with lower urinary citrate excretion, putting patients at risk for kidney stones, according to a study presented at the National Kidney Foundation 2013 Spring Clinical Meetings. "Hypocitraturia from topiramate is rapid and progressive," researcher Allan Jhagroo said. "This should be taken into account when starting therapy, particularly in patients with a history of urolithiasis or with identifiable lithogenic risk factors."

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC